S
AUPH icon

SignatureFD’s Aurinia Pharmaceuticals AUPH Stock Holding History

SignatureFD’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-179
Closed -$1.98K – 3418
2025
Q3 		$1.98K Hold
179
– – ﹤0.01% 2955
2025
Q2 		$1.52K Sell
179
-111
-38% -$890 ﹤0.01% 2936
2025
Q1 		$2.33K Buy
290
+43
+17% +$348 ﹤0.01% 2833
2024
Q4 		$2.22K Buy
247
+68
+38% +$555 ﹤0.01% 2841
2024
Q3 		$1.31K Hold
179
– – ﹤0.01% 2942
2024
Q2 		$1.02K Buy
+179
New +$943 ﹤0.01% 2897
2023
Q1 		– Sell
-52
Closed -$225 – 3283
2022
Q4 		$225 Buy
52
+21
+68% +$122 ﹤0.01% 3181
2022
Q3 		$0 Buy
+31
New +$268 ﹤0.01% 3107
2022
Q1 		– Sell
-140
Closed -$3K – 3136
2021
Q4 		$3K Buy
+140
New +$3.32K ﹤0.01% 2551

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SignatureFD's AUPH Position: Q4 2025 in Review

SignatureFD sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2025, closing a stake of 179 shares — an estimated $1.98K sold.

SignatureFD first reported a position in AUPH in Q4 2021 and held it in 9 quarters. The position peaked at $3K in Q4 2021. 255 funds tracked by Wall St. Rank hold AUPH as of Q4 2025.

  • SignatureFD reported no remaining Aurinia Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • SignatureFD sold 179 Aurinia Pharmaceuticals shares in Q4 2025, an estimated $1.98K.
  • SignatureFD first reported a position in Aurinia Pharmaceuticals in Q4 2021 and held it in 9 quarters.
  • SignatureFD's Aurinia Pharmaceuticals position peaked at $3K in Q4 2021.
  • 255 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2025.

Based on SignatureFD's 13F filing for Q4 2025, filed 20 Jan 2026.